9 September 2025NewsCareersMuireann Bolger

UK gets new IP minister following cabinet reshuffle

Wales’ first MP of ethnic minority background brings tech knowledge and expertise to the IP office, which is carrying out two pivotal consultations.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Careers
8 September 2025   The US firm has ramped up its business growth strategy with the new hires, who will represent different IP practice and industry areas.
Careers
8 September 2025   Appointment is the third ex-PTAB staffer to join, strengthens the firm’s position as a “PTAB powerhouse”.
Careers
11 August 2025   The trio bring experience in patent, trade secret, and commercial disputes across high tech, biotech, and life sciences, with two returning to Weil after more than a decade.

More on this story

Careers
8 September 2025   The US firm has ramped up its business growth strategy with the new hires, who will represent different IP practice and industry areas.
Careers
8 September 2025   Appointment is the third ex-PTAB staffer to join, strengthens the firm’s position as a “PTAB powerhouse”.
Careers
11 August 2025   The trio bring experience in patent, trade secret, and commercial disputes across high tech, biotech, and life sciences, with two returning to Weil after more than a decade.

More on this story

Careers
8 September 2025   The US firm has ramped up its business growth strategy with the new hires, who will represent different IP practice and industry areas.
Careers
8 September 2025   Appointment is the third ex-PTAB staffer to join, strengthens the firm’s position as a “PTAB powerhouse”.
Careers
11 August 2025   The trio bring experience in patent, trade secret, and commercial disputes across high tech, biotech, and life sciences, with two returning to Weil after more than a decade.